Cart
sales@molnova.com
Wnt pathway inhibitor 3
CAS No. 663213-98-7
Wnt pathway inhibitor 3( —— )
Catalog No. M36918 CAS No. 663213-98-7
Wnt pathway inhibitor 3 is a potent AC1 inhibitor (IC50: 45 nM) with antiproliferative activity, suitable for studies to ameliorate osteoarthritis in a mouse model of experimental osteoarthritis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 31 | In Stock |
|
| 25MG | 52 | In Stock |
|
| 50MG | 74 | In Stock |
|
| 100MG | 111 | In Stock |
|
| 200MG | 163 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameWnt pathway inhibitor 3
-
NoteResearch use only, not for human use.
-
Brief DescriptionWnt pathway inhibitor 3 is a potent AC1 inhibitor (IC50: 45 nM) with antiproliferative activity, suitable for studies to ameliorate osteoarthritis in a mouse model of experimental osteoarthritis.
-
DescriptionWnt pathway inhibitor 3 is a potent wnt inhibitor with an IC50 value of 45 nM. Wnt pathway inhibitor 3 shows antiproliferative activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayWnt/Notch/Hedgehog
-
TargetWnt/beta/catenin
-
RecptorWnt/beta-catenin | Adenylyl cyclase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number663213-98-7
-
Formula Weight457.27
-
Molecular FormulaC21H17BrN2O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(#N)C=1C(C2=C(C=C3C(=C2)OCO3)OC1N)C4=CC(OC)=C(OCC=C)C(Br)=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Michael Boutros, et al. Chromene derivatives and their analoga as wnt pathway antagonists. US20130296344A1.
molnova catalog
related products
-
KY02111
KY02111 promotes differentiation of hPSCs to cardiomyocytes by inhibiting Wnt signaling.
-
Roquinimex
Roquinimex (Linomide) is a quinoline derivative immunostimulant which increases NK cell activity and macrophage cytotoxicity; inhibits angiogenesis and reduces the secretion of TNF alpha.
-
WWL70
WWL70 is a selective alpha/beta hydrolase domain 6 inhibitors (IC50: 70 nM). WWL70 (10 μM, 1 h) treatment, 2-Arachidonoylglycerol is increased by 20% compared to untreated cells.
